Rodriguez, Alfredo E <br/><br/>
Sirolimus-eluting stents or vascular brachytherapy for in-stent restenosis after 3-year follow-up of the SISR (Sirolimus-Eluting Stent Versus Vascular Brachytherapy for In-Stent Restenosis) trial: a call for caution?  [electronic resource] 

 -  JACC. Cardiovascular interventions  Jan 2009 
 - 75-6; author reply 76-7 p.  digital 
<br/><br/> Publication Type: Comment; Letter 
<br/><br/><label>ISSN: </label>1876-7605 
<br/><br/><label>Standard No.: </label>10.1016/j.jcin.2008.11.001  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Brachytherapy<br/>Coronary Restenosis--drug therapy<br/>Drug-Eluting Stents<br/>Humans<br/>Immunosuppressive Agents--therapeutic use<br/>Sirolimus--therapeutic use